MTRC is developing a novel digital product - Reimbursement and HTA Market Intelligence Database, which will allow access to the historical reimbursement/HTA decisions for individual technology groups (e.g. cardiovascular, robotic, IVD etc.), for individual countries, filtering decisions by type of decision (e.g. procedure coding, payment mechanisms, innovation funding etc.). There will be a small overlap between the upcoming database product and the existing Reimbursement and HTA Alerts newsletter; however, the database will offer much broader functionality and several additional benefits. We invite our existing and prospective clients to comment on the design of the upcoming solution.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Benedetto et al. conducted a systematic review to evaluate the analytical frameworks and outcome measures used in economic evaluations of digital health interventions (DHIs). By synthesizing arguments from 15 studies, the authors identified limitations in using traditional health-related quality of life measures and proposed a set of methodological recommendations, including the use of impact matrices, cost-consequence analysis, and analyses of equity impacts. This review provides valuable insights for future economic evaluations of DHIs and advances the understanding of measuring their effects beyond health outcomes.

On May 15, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to controlling drug prescriptions in outpatient settings, evaluating the effectiveness of outpatient extensive stuttering therapy in primary school children, and the efficacy of cross-sectoral care models in psychiatry.

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Veldwijk et al. conducted a study to assess the importance of criteria describing methods for decision-makers in the medical product lifecycle (MPLC) and evaluate the suitability of various preference elicitation methods at each decision point. Using multicriteria decision analysis, an online survey was conducted among MPLC decision makers, who ranked and weighted 19 methods criteria. The results showed that criteria related to estimating trade-offs and weights for treatment characteristics were consistently important across all MPLC decision points. Additionally, swing weighting and probabilistic threshold techniques were found to be more suitable than other methods. The study highlights the need to consider other preference elicitation methods and suggests the development of evidence-based guidelines for their effective utilization.

In May 2023, the government revised the national budget and proposed changes in the central health administration's roles, organization, and responsibilities to be implemented on January 1, 2024. The reorganization includes the merger of the Directorate of Health and the Directorate of e-Health.

On April 5, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of thirty-five applications for Innovation Funding of healthcare research projects were accepted. A total of 231 applications were received in response to the funding announcement of June 27, 2022 (changed on September 20, 2022), and thirty-five of them were accepted.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Egholm et al. investigated the implementation of a national patient-reported outcomes (PRO) policy in Denmark which aims to enhance patient-centered approaches in healthcare and realize benefits at the individual patient level. The paper outlines the three key elements: developing standardized PRO instruments within specific clinical areas, establishing a PRO instrument repository, and creating a national IT infrastructure for data sharing. Furthermore, the authors provided an overview of the progress made after six years of implementation, highlighting the promising value of PRO instruments for both patients and healthcare professionals, as well as challenges in operationalizing the IT infrastructure and implementation across healthcare sectors.

On May 17, 2023, the Ministry of Health and Prevention published the 2023-2027 Digital Health Roadmap. The new roadmap specifies the priorities and the projects to be carried out by 2027. One of the key objectives is to support the implementation and extension of telemonitoring to more chronic pathologies.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Caro noted the increasing use of models to forecast disease outcomes and intervention effects, particularly highlighted during the COVID-19 pandemic. To address the need for validation and systematic critical review of increasing numbers of models, the journal Pharmacoeconomics is launching a series of papers focusing on critical reviews of modeling approaches in specific disease areas, including pharmaceutical and non-pharmaceutical interventions, as well as diagnostic procedures. The short introduction outlines the scope and coverage of the review papers in the series.

In late May 2023, the Norwegian Directorate of e-Health released an updated version of the Norwegian Laboratory code (NLK) system to be implemented no later than July 1, 2023. A total of 142 new codes were added, 33 codes were terminated, and 122 codes were amended.

On May 17, 2023, NHS England issued an updated version of the National Genomic Test Directory for cancer, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Two new codes (test-indication combinations) were introduced.